Comparison of the effect of curcumin tablets with metronidazole tablets on the treatment of bacterial vaginosis
- Conditions
- Condition 1: Bacterial vaginosis treatment. Condition 2: Vaginosobacterial treatment with nanocurcumin 40 capsules.
- Registration Number
- IRCT20120414009463N61
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 90
1- Age 18- 49 years
2. Being married
3 - Do not be menopause
4 - No pregnancy and lactation
5- proof of bacterial vaginosis
6- Not having allergies to curcumin (turmeric) or other medicinal plants
7. No history of known chronic disease
8. Not using herbal medicines and chemicals related to the treatment of genital infections during the last two weeks
9 - No active gastrointestinal ulcers and also no bile problems and gallstones
1.Pregnancy during treatment
2. The presence of other vaginal infections
3. Complications or allergies to curcumin
4. The reluctance of the participant to continue the research
5 - not following the correct method of treatment (forgetting to take medicine for more than one night)
6- Use of systemic antibiotics to treat non-bacterial systemic infection during treatment
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary outcome is the percentage of people who have improved after taking oral curcumin tablets to treat bacterial vaginosis. Timepoint: Periods of disease evaluation, before the intervention and two weeks after starting metronidazole and curcumin tablets. Method of measurement: Existence of three of Amsel's four standard signs.
- Secondary Outcome Measures
Name Time Method